My major research interest is in radiation therapy for lymphomas, genitourinary cancers—including prostate cancer, bladder cancer and seminoma—and late effects of treatment, especially second cancers. Current research activities include study of image guided precision radiotherapy. I also have a long-standing interest in cancer classification with an emphasis on staging and prognostic factors. In addition, my current interests include the application of modern information and communication technologies in cancer control.
Mary K Gospodarowicz
Localized orbital mucosa-associated lymphoma tissue lymphoma managed with primary radiation therapy: efficacy and toxicity.
Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e659-66
Patient-specific PTV margins in radiotherapy for bladder cancer - a feasibility study using cone beam CT.
Radiother Oncol. 2011 May;99(2):131-6
High response rate and improvement of long-term survival with combined treatment modalities in patients with poor-risk primary thyroid diffuse large B-cell lymphoma: an International Extranodal Lymphoma Study Group and Intergruppo Italiano Linfomi study.
Leuk Lymphoma. 2011 May;52(5):823-32
Radiother Oncol. 2011 Aug;100(2):304-7
Nat Rev Clin Oncol. 2011 Mar;8(3):129-30
Non-risk-adapted surveillance in clinical stage I nonseminomatous germ cell tumors: the Princess Margaret Hospital's experience.
Eur Urol. 2011 Apr;59(4):556-62
Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):e781-6
Lancet. 2010 Oct 2;376(9747):1186-93
'Evidence-based medicine: the time has come to set standards for staging'. Is a radical overhaul really needed?
J Pathol. 2010 Aug;221(4):361-2
Long-term outcome in localized extranodal mucosa-associated lymphoid tissue lymphomas treated with radiotherapy.
Cancer. 2010 Aug 15;116(16):3815-24
Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre
Professor, Department of Radiation Oncology, University of Toronto
President, Union for International Cancer Control (UICC)